Study update

5

Oct, 2018

EPIICAL: enrollment has completed in the CARMA study!

 

September saw the CARMA study complete its enrollment target of 40 patients. Reservoir size assays have been performed, and primary statistical analyses are ongoing. Over the coming weeks, some results relating immunological and virological assays will be released and discussed internally within the EPIICAL Consortium at General Assembly meeting in November.

READ MORE
NEWSLETTER

We would like to update you on our recent activities